Value of DCE-MRI and FDG-PET/CT in the prediction of response to preoperative chemotherapy with bevacizumab for colorectal liver metastases.

Br J Cancer · 2012 · PMC3388560 · PMID 22596235

Europe PMC DOI

hedged sentence

0.1700

closest p · 3.4× alpha

0.1700

boldest claim

The sentences

showed a trendP =0.170not close (p > 0.1)

Using univariate analysis, the follow-up SUV max showed a trend for a worse survival with higher SUV max (HR 1.196, 95% CI 0.926–1.543, P =0.170).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.